- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03687996
Pratical Assessment of DSAEK in the Management of Endothelial Decompensation Following Penetrating Keratoplasty (MADE)
September 26, 2018 updated by: Centre Hospitalier Régional Metz-Thionville
Pratical Assessment of Descemet'Sstripping Automated Endothelial Keratoplasty (DSAEK) in the Management of Endothelial Decompensation Following Penetrating Keratoplasty
Reporting our anatomical and functional results and the possible complications of the first six Descemet's stripping endothelial keratoplasty (DSAEK) performed in our department secondary to endothelial decompensation after penetrating keratoplasty.
Study Overview
Status
Completed
Detailed Description
A retrospective and observational monocentric study fo six patients with DSAEK after prior penetrating keratoplasty (PK).
The data collected are: demographic characteristics, ophthalmological comorbidities, initial indication of PK, delay between PK and DSAEK.
Preoperative Visual Acuity and at 1, 3 and 6 months postoperative were collected in logmar for analysis.
The central cornea and graft thickness measured in OCT as well as the postoperative complications were also collected.
Study Type
Observational
Enrollment (Actual)
6
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who profited of the first Descemet's stripping endothelial keratoplasty to endothelial decompensation after penetrating keratoplasty
Description
Inclusion Criteria:
- with endothelial decompensation after penetrating keratoplasty
- surgery realised by the same surgeon
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual acuity
Time Frame: change from visual acuity at 6 month
|
pre and postoperative visual acuity in logmar
|
change from visual acuity at 6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cornea thickness
Time Frame: change from cornea thickness at 6 month
|
the central cornea and graft thickness measured in OCT
|
change from cornea thickness at 6 month
|
postoperative complications
Time Frame: month 6
|
all the postoperative complications were collected
|
month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
July 31, 2016
Study Registration Dates
First Submitted
September 25, 2018
First Submitted That Met QC Criteria
September 26, 2018
First Posted (Actual)
September 27, 2018
Study Record Updates
Last Update Posted (Actual)
September 27, 2018
Last Update Submitted That Met QC Criteria
September 26, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 2015-15Obs-CHRMT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Descemet's Stripping Automated Endothelial Keratoplasty
-
Aarhus University HospitalWithdrawnEndothelial Dystrophy | Secondary Bullous Keratopathy | Posterior Lamellar Keratoplasty | Descemet's Stripping Endothelial KeratoplastyDenmark
-
Oslo University HospitalRecruitingDescemet Stripping Automated Endothelial Keratoplasty (DSAEK) | Descemet Membrane Endothelial Keratoplasty (DMEK)Norway
-
Oslo University HospitalUnknownCorneal Dystrophies, Hereditary | Fuchs' Endothelial Dystrophy | Corneal Transplantation | Descemet Stripping Automated Endothelial KeratoplastyNorway
-
Case Western Reserve UniversityNational Eye Institute (NEI); Jaeb Center for Health ResearchCompletedCornea Preservation Time | Endothelial Keratoplasty | Transplant Success | Endothelial Cell DensityUnited States
-
ProQR TherapeuticsWithdrawnCorneal Diseases | Fuchs Endothelial Corneal Dystrophy | FECD3 | LRS | Descemet's Membrane DisorderUnited Kingdom
-
Centre Hospitalier Régional Metz-ThionvilleCompletedPseudophakic Bullous Keratopathy | Fuchs' Endothelial Corneal Dystrophy | Descemet Membrane Endothelial Keratoplasty | Graft DetachmentFrance
-
Beyoglu Eye Research and Education HospitalCompletedEndothelial Dysfunction | Fuchs' Endothelial Dystrophy | Pseudophakic Bullous Keratopathy | Herpetic Keratitis | Descemet's Membrane; Defect | Angle's ClassificationTurkey